EU Market Access Program
In recent years BFC developed a special program to support pharmaceutical companies with the marketing of pharmaceutical products. It includes all necessary elements to be taken care of before, during, or after the launch of such a product on the Dutch or European market.These elements are:
- EU Marketing authorization approval process
- Supply chain support and distribution strategy
- Additional licensing activities e.g. for opioid distribution
- Pricing & reimbursement applications
- Promotion and advertising compliance monitoring, including website design
- Pharmacovigilance systems including interfacing with EudraVigilance
- Post-Approval Committment implementations
In particular foreign companies, new to the Dutch pharmaceutical environment, may benefit significantly from such a program which will be tailored to the needs of the product and its company
We have ample experience with supporting such companies with their entry in the Dutch market and we have compiled massive experience with each of these elements during over 20 years of continued pharmaceutical consultancy. This massive experience is the very basis of the Market Access Program.
